Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.82M Sell
81,672
-15,660
-16% -$1.81M 0.15% 207
2025
Q4
$10.2M Buy
97,332
+8,617
+10% +$809K 0.16% 186
2025
Q3
$7.45M Buy
88,715
+968
+1% +$79.7K 0.12% 278
2025
Q2
$6.95M Buy
+87,747
New +$6.97M 0.15% 228
2024
Q3
Sell
-2,628
Closed -$325K 1433
2024
Q2
$325K Buy
+2,628
New +$339K 0.01% 1095
2024
Q1
Sell
-4,928
Closed -$537K 1198
2023
Q4
$537K Buy
4,928
+517
+12% +$53.7K 0.02% 805
2023
Q3
$454K Buy
+4,411
New +$475K 0.02% 774
2023
Q1
Sell
-2,483
Closed -$275K 1247
2022
Q4
$275K Sell
2,483
-18,218
-88% -$1.86M 0.02% 948
2022
Q3
$1.78M Buy
20,701
+1,145
+6% +$102K 0.11% 308
2022
Q2
$1.78M Buy
+19,556
New +$1.73M 0.13% 230
2019
Q3
Sell
-4,298
Closed -$344K 412
2019
Q2
$344K Buy
+4,298
New +$329K 0.13% 207

Other funds holding MRK

Algert Global's MRK Position: Q1 2026 in Review

Algert Global reduced its Merck (MRK) stake by 16% in Q1 2026, selling an estimated $1.81M and leaving 81,672 shares worth $9.82M. The position accounts for 0.15% of the portfolio, ranked #207.

Algert Global first reported a position in MRK in Q2 2019 and has held it in 11 quarters since. The position peaked at $10.2M in Q4 2025. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Algert Global held 81,672 shares of Merck worth $9.82M as of Q1 2026.
  • Algert Global sold 15,660 Merck shares in Q1 2026, an estimated $1.81M.
  • Merck made up 0.15% of Algert Global's portfolio in Q1 2026, its #207 holding.
  • Algert Global first reported a position in Merck in Q2 2019 and has held it in 11 quarters since.
  • Algert Global's Merck position peaked at $10.2M in Q4 2025.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.